Multiparameter analysis of AgNOR in thyroid lesions: Comparison with PCNA expression

Histology and Histopathology

Volumn 19, Issue 3, 2004, Pages 785-792

  Slowinska Klencka D ^a   Klencki, M ^a   Popowicz, B ^a   Sporny, S ^a   Lewiński, Andrzej ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

AgNOR; Computer aided analysis; Follicular lesions; Neoplasm; Thyroid

Indexed keywords

CYCLINE; PARAFFIN;

ANALYTICAL PARAMETERS; ANAPLASTIC CARCINOMA; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CHROMOSOME NOR; COMPUTER SYSTEM; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; INTERMETHOD COMPARISON; NODULAR GOITER; PROTEIN EXPRESSION; SILVER STAINING; STATISTICAL SIGNIFICANCE; THYROID ADENOMA; THYROID DISEASE; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; THYROID PARAFOLLICULAR CELL; THYROID TUMOR;

ADENOCARCINOMA, FOLLICULAR; ADENOMA; ADENOMA, OXYPHILIC; ANTIBODIES, MONOCLONAL; CARCINOMA, PAPILLARY, FOLLICULAR; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MULTIVARIATE ANALYSIS; NUCLEOLUS ORGANIZER REGION; PROLIFERATING CELL NUCLEAR ANTIGEN; SILVER STAINING; THYROID NEOPLASMS;

EID: 3042704111     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Ahiskali R., Alican Y., Ekicioglu G., Çevik I., Küllü S. and Akdas A. (1995). Evaluation of three different AgNOR counting methods in advenced carcinoma of the prostate. Prostate 26, 105-110.
2. Aogi K., Kitahara K., Buley I., Backdahl M., Tahara H., Sugino T., Tarin D. and Goodison S. (1998). Telomerase activity in lesions of the thyroid: application to diagnosis of clinical samples including fine-needle aspirates. Clin. Cancer Res. 4, 1965-1970.
3. Aubele M., Biesterfeld S., Derenzini M., Hufnagl P., Martin H., Öfner D., Ploton D. and Rüschoff J. (1994). Guidelines of AgNOR quantitation. Zentralbl. Pathol. 140, 107-108.
4. Bankfalvi A., Schmitz K., Mock T., Kemper M., Cubick C. and Bocker W. (1998). Relationship between AgNOR proteins, Ki-67 antigen, p53 immunophenotype and differentiation markers in archival breast carcinomas. (1998) Anal. Cell. Pathol. 17, 231-242.
5. Canet V., Montmasson M.P., Usson Y., Giroud F. and Brugal G. (2001). Correlation between silver-stained nucleolar organizer region area and cell cycle time. Cytometry 43, 110-116.
6. Cor A. (1999). Proliferative activity of Hurthle cell thyroid tumours. Oncology 57, 17-22.
7. Derenzini M. (2000). The AgNORs. Micron 31, 117-120.
8. Derenzini M. and Trere D. (1991). Standardization of interphase Ag-NOR measurement by means of an automated image analysis system using lymphocytes as an internal control. J. Pathol. 165, 337-342.
9. Derenzini M. and Trere D. (1994). AgNOR proteins as a parameter of the rapidity of cell proliferation. Zentralbl. Pathol. 140, 7-10.
10. Gasbarri A., Martegani M.P., Del Prete F., Lucante T., Natali P.G. and Bartolazzi A. (1999). Galectin-3 and CD44v6 isoforms in the preoperative evaluation of thyroid nodules. J. Clin. Oncol. 17, 3494-3502.
11. Howat A.J., Girl D.D., Cotton D.W.K. and Slater D.N. (1989). Nucleolar organizer regions in spitz nevi and malignant melanomas. Cancer 63, 474-478.
12. Howell W.M. (1982). Selective staining of nucleolus organiser regions (NORs). In: The cell nucleus. Vol IX. Busch H. and Rothblum L. (eds). Academic. New York. pp 89-143.
13. Hufnagl P., Guski H. and Schultz H.J. (1994) Measuring of AgNORs using image analysis. Zentralbl. Pathol. 140, 31-35.
14. Irazusta S.P., Vassallo J., Magna L.A., Metze K. and Trevisan M. (1998). The value of PCNA and AgNOR staining in endoscopic biopsies of gastric mucosa. Pathol. Res. Pract. 194, 33-39.
15. Karmakar T. and Dey P. (1995). Role of AgNOR in diagnosis of thyroid follicular neoplasms on fine-needle aspiration smears. Diagn. Cytopathol. 12, 148-149; discussion 149-151.
16. Khan E.M. and Pandey R. (1996). Differential diagnosis of fine needle aspiration smears of thyroid nodules. Cytologic features and AgNORs. Acta. Cytol. 40, 959-962.
17. Klencki M., Slowińska-Klencka D. and Lewiński A. (2001a). Computer system for quantitative analysis of argyrophilic nucleolar organising regions (AgNORs). Folia Histochem. Cytobiol. 39 (suppl. 3): 45.
18. Klencki M., Kurnatowska I., Slowińska-Klencka D., Lewiński A. and Pawlikowski M. (2001b). Correlation between PCNA expression and AgNOR dots in pituitary adenomas. Endocr. Pathol. 12, 163-169.
19. Lewy-Trenda I. and Bienkiewicz M. (1999). Evaluation of MIB-1 immunoreactivity and nucleolar organizer regions in nonneoplastic and neoplastic thyroid lesions. Pol. J. Pathol. 50, 129-138.
20. Mehrotra A., Agarwal P.K. and Chandra T. (1998). Cytopathology and AgNOR counts in fine-needle aspiration cytology smears of thyroid lesions. Diagn. Cytopathol. 19, 238-243.
21. Mehrotra A., Goel M.M. and Singh K. (2002). Ki-67 and AgNOR proliferative markers as diagnostic adjuncts to fine needle aspiration cytology of thyroid follicular lesions. Anal. Quant. Cytol. Histol. 24, 205-211.
22. Nairn E.R., Crocker J. and McGovern J. (1988). Limited value of AgNOR enumeration in assessment of thyroid neoplasms. J. Clin. Pathol. 41, 1136.
23. Öfner D., Hittmair A., Marth C., Ofner C., Totsch M., Daxenbichler G., Mikuz G., Margreiter R. and Schmid K.W. (1992). Relationship between quantity of silver stained nucleolar organizer regions associated proteins (Ag-NORs) and population doubling time in ten breast kancer cell lines. Pathol. Res. Pract. 188, 742-746.
24. Pich A., Chiusa L. and Margaria E. (2000). Prognostic relevance of AgNORs in tumor pathology. Micron 31, 133-141.
25. Ploton D., Menager M., Jeanneson P., Himber G., Pigeon F. and Adnett J. (1986). Improvement in the staining and visualization of the argyrophylic proteins of the nucleolar organizer regions at the optical level. Histochem. J. 18, 5-14.
26. Rüschoff J., Presser Ch., Cortez T., Höhne H.M. and Hohenberger W., Hofstädter F. (1993). Diagnostic value of AgNOR staining in follicular cell neoplasms of the thyroid: comparison of evaluation methods and nucleolar features. Am. J. Surg. Pathol. 17, 1281-1288.
27. Shechtman L., Koren R., Horowitz A., Shechtman I., Halpern M. and Gal R. (1998). Diagnostic value of AgNOR staining in thyroid cytology. Anal. Quant. Cytol. Histol. 20, 187-191.
28. Shem-Tov Y., Straus M., Talmi Y.P., Rath-Wolfsom L., Zohar Y. and Gal R. (1994). Nucleolar organizer regions in follicular tumors of the thyroid. Head Neck 16, 420-423.
29. Sirri V., Roussel P. and Hernandez-Verdun D. (2000). The AgNOR proteins: qualitative and quantitative changes during the cell cycle. Micron 31, 121-126.
30. Slowińska-Klencka D., Klencki M., Popowicz B., Lewiński A. (2004). AgNOR quantification in the diagnosis of thyroid lesions. Anal. Quant. Cytol. Histol. (in press).
31. Slowińska-Klencka D., Popowicz B., Klencki M., Lewiński A. (2003). Morphometric analysis of AgNOR dots in autoimmunological lesions of the thyroid. 6th European Congress of Endocrionology. Lyon 26-30 April 2003, Abstract book P0974
32. Solymosi T., Tóth V., Sápi Z., Bodó M., Gál I. and Csanádi L. (1996). Diagnostic value of AgNOR method in thyroid cythopathology: correlation with morphometric measurements. Diagn. Cytopathol. 14, 140-144.
33. Trere D. (2000). AgNOR staining and quantification. Micron 31, 127-131.
34. Vassko V., Garcia S., Henry J.F. and De Micco C. (1999) Expression of proliferating cell nuclear antigen in follicular thyroid tumors: correlation with clinicopathological findings. Oncol. Rep. 6, 359-364.
35. Zaczek M., Szot W. and Chlap Z. (1996). Argyrophilic nucleolar organizer regions in proliferative lesions of the thyroid gland. Anal. Quant. Cytol. Histol. 18, 1-8.